secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2025-08-15T23:59:59+00:00
Accession:  0001213900-25-077497
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive sells 3.55M shares for ~$16.3M net via ATM offering
-------------------------------------------------------------

- Sold 3,549,846 shares at average $4.56 per share since June 30, 2025.
- Net proceeds after fees approximately $16.3 million.
- Sales executed under November 2024 sales agreement with Guggenheim Securities.
- Stock trades on Nasdaq Capital Market under ticker UNCY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025077497/0001213900-25-077497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390025077497/ea0253521-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-077497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer